Business Description
AstraZeneca PLC
NAICS : 325412
ISIN : GB0009895292
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.73 | |||||
Debt-to-EBITDA | 2.09 | |||||
Interest Coverage | 5.47 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.77 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | 14 | |||||
3-Year EPS without NRI Growth Rate | 37.2 | |||||
3-Year FCF Growth Rate | 38.8 | |||||
3-Year Book Growth Rate | 31.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 11.09 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.9 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.11 | |||||
9-Day RSI | 63.53 | |||||
14-Day RSI | 62.21 | |||||
6-1 Month Momentum % | -2.48 | |||||
12-1 Month Momentum % | -14.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.82 | |||||
Quick Ratio | 0.64 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 225.57 | |||||
Days Sales Outstanding | 77.3 | |||||
Days Payable | 579.92 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.09 | |||||
Dividend Payout Ratio | 0.72 | |||||
3-Year Dividend Growth Rate | 2.9 | |||||
Forward Dividend Yield % | 2.09 | |||||
5-Year Yield-on-Cost % | 2.23 | |||||
3-Year Average Share Buyback Ratio | -5.7 | |||||
Shareholder Yield % | 2.83 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 81.96 | |||||
Operating Margin % | 19.05 | |||||
Net Margin % | 13.03 | |||||
FCF Margin % | 14.37 | |||||
ROE % | 15.93 | |||||
ROA % | 6.1 | |||||
ROIC % | 8.68 | |||||
ROC (Joel Greenblatt) % | 86.78 | |||||
ROCE % | 12.1 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 35.39 | |||||
Forward PE Ratio | 16.13 | |||||
PE Ratio without NRI | 33.27 | |||||
Shiller PE Ratio | 61.7 | |||||
Price-to-Owner-Earnings | 23.54 | |||||
PEG Ratio | 5.2 | |||||
PS Ratio | 4.63 | |||||
PB Ratio | 5.47 | |||||
Price-to-Free-Cash-Flow | 32.24 | |||||
Price-to-Operating-Cash-Flow | 20.44 | |||||
EV-to-EBIT | 27.48 | |||||
EV-to-Forward-EBIT | 15.71 | |||||
EV-to-EBITDA | 17.38 | |||||
EV-to-Forward-EBITDA | 13.13 | |||||
EV-to-Revenue | 5.11 | |||||
EV-to-Forward-Revenue | 4.57 | |||||
EV-to-FCF | 35.46 | |||||
Price-to-Projected-FCF | 2.86 | |||||
Price-to-DCF (Earnings Based) | 1.07 | |||||
Price-to-DCF (FCF Based) | 2.37 | |||||
Price-to-Median-PS-Value | 1.05 | |||||
Earnings Yield (Greenblatt) % | 3.64 | |||||
FCF Yield % | 3.11 | |||||
Forward Rate of Return (Yacktman) % | 6.51 |